Global Care closes sale of ReFormation to 360 Life
Global Care closes sale of ReFormation to 360 Life
2020-08-04 16:44 ET - News Release
Mr. Alex Somjen reports
GLOBAL CARE CAPITAL COMPLETES SALE OF SUBSIDIARY
Global Care Capital Inc. has closed the previously announced sale of all of the issued and outstanding shares of its wholly owned subsidiary, ReFormation Pharmaceuticals Corp., to 360 Life Sciences Corp., pursuant to the share purchase agreement between Global Care and the purchaser signed on June 24, 2020. The purchaser acquired all the issued and outstanding shares of ReFormation in exchange for 800,000 common shares of the purchaser.